<DOC>
	<DOCNO>NCT00356395</DOCNO>
	<brief_summary>hypothesize combination therapy additive beneficial effect improve endothelial dysfunction adipocytokine profile patient hypertension .</brief_summary>
	<brief_title>Safety Effects Ramipril Combined With Candesartan</brief_title>
	<detailed_description>Forty patient give ramipril 10 mg placebo , ramipril 10 mg candesartan 16 mg , candesartan 16 mg placebo daily randomize , double-blind , placebo-controlled cross-over trial three treatment arm two washout period ( 2 month ) .</detailed_description>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>patient mild moderate hypertension We exclude patient severe hypertension , unstable angina , acute myocardial infarction , renal insufficiency .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>endothelial function , insulin resistance , adipocytokines</keyword>
</DOC>